NCT07057557 Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites
| NCT ID | NCT07057557 |
| Status | Recruiting |
| Phase | — |
| Sponsor | King Edward Medical University |
| Condition | Skin Graft Wounds |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2025-08-05 |
| Primary Completion | 2026-02-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2025-08-05 with a primary completion date of 2026-02-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if Aloe Vera gel dressing helps reduce pain better than traditional paraffin-based tulle dressing at the donor site of split-thickness skin grafts in adult patients aged 18 to 60. The main questions it aims to answer are: Does Aloe Vera gel dressing reduce postoperative pain more effectively than paraffin-based tulle dressing on the 7th day after surgery? Is there a difference in the need for additional pain medication between the two groups? Researchers will compare Aloe Vera gel dressing to paraffin-based tulle dressing to see if Aloe Vera leads to better pain control. Participants will: Undergo split-thickness skin graft surgery Receive either Aloe Vera gel dressing or paraffin-based tulle dressing at the donor site Have pain measured using a visual analogue scale (VAS) on the 7th day after surgery Be given pain medication if their pain score is 4 or higher, and the amount used will be recorded
Eligibility Criteria
Inclusion Criteria: * • Patients aged 18-60 years of age of either gender needing Split thickness skin graft Exclusion Criteria: * • Patients known to have exaggerated/diminished pain response due to certain medical conditions (e.g. diabetes, neuropathy, chemotherapy, opioids etc.) * Patients allergic to either dressings
Frequently Asked Questions
Who can join the NCT07057557 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 60 Years, studying Skin Graft Wounds. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07057557 currently recruiting?
Yes, NCT07057557 is actively recruiting participants. Visit ClinicalTrials.gov or contact King Edward Medical University to inquire about joining.
Where is the NCT07057557 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT07057557 clinical trial?
NCT07057557 is sponsored by King Edward Medical University. The trial plans to enroll 72 participants.